Skip to product information
1 of 1
Sold Out

Antiangiogenic Cancer Therapy

Antiangiogenic Cancer Therapy

Hardback

Regular price £372.93
Regular price Sale price £372.93

Join our rewards scheme and earn 1119 reward points on this purchase!

Earn 1119 points on this!

Sign in or Sign up!
View full details
  • Release Date: 25/07/2007
  • Barcode: 9780849327995
  • Genre: Medicine
  • Label: CRC Press Inc
  • Publisher: Taylor & Francis Inc
Antiangiogenic Cancer Therapy

Antiangiogenic Cancer Therapy

Collapsible content

DESCRIPTION

Offers information on the process of angiogenesis and its role in tumor growth and metastasis. This title compiles the work of experts to explore angiogenesis inhibitors under clinical investigation, as well as early agents used in preclinical studies. It discusses the unique aspects of targeting and inhibiting angiogenesis.

Top Investigators Explore the Complexities of Angiogenesis Cancer Research

The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical application of angiogenesis inhibitors.

Compiles the results of four decades of progress

Integrating fundamental concepts with therapeutic strategies, Anti-Angiogenic Cancer Therapy promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis leads to optimal therapeutic strategies and positive clinical results. It brings together contributions from leading researchers to provide the most authoritative and encyclopedic volume available on this subject.

  • Examines the role of angiogenesis in cancer, including strategies to prolong the nonangiogenic dormant state of human tumors, molecular mechanisms and cellular regulation of angiogenesis in solid tumors and hematologic malignancies, and the regulation of angiogenesis by the tumor microenvironment.
  • Covers specific molecular targets for inhibiting angiogenesis in cancer therapy.
  • Discusses clinical trial design and translational research approaches essential for identifying and developing effective angiogenesis inhibitors.
  • Outlines current understanding of the molecular biology of each cancer type followed by discussions that examine strategies for targeting angiogenesis in specific cancers.
  • This volume celebrates progress made in four decades, and more importantly, it provi


    DELIVERY & RETURNS

    UK Delivery:

    • Free delivery on all orders of £10 or more.
    • £1.49 delivery fee on orders below £10.
    • UK orders are shipped via Royal Mail 2nd Class.

    International Delivery:

    • Flat rate delivery charges vary by country.

    Dispatch and Delivery Times:

    • All orders are shipped from our warehouse in Northampton, UK within 48 hours of receipt during working hours.
    • UK mainland orders typically arrive within 3-5 working days via Royal Mail 2nd Class.
    • International estimated delivery times:
    • Europe & Channel Islands: 7 to 10 working days
    • USA: 7 to 15 working days
    • Rest of the World: 9 to 21 working days

    View our full delivery infomation here.

    • OVER

      2 MILLION PRODUCTS

    • 60 MILLION CUSTOMERS

      ACROSS 190 COUNTRIES